Barbara Oil Co. maintained its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 15,000 shares of the pharmacy operator’s stock at the end of the second quarter. Barbara Oil Co.’s holdings in Walgreens Boots Alliance were worth $1,175,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of WBA. Hudock Capital Group LLC boosted its stake in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after purchasing an additional 6 shares during the period. Reilly Financial Advisors LLC boosted its stake in Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the period. Orrstown Financial Services Inc. boosted its stake in Walgreens Boots Alliance by 14.1% during the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares during the period. Private Vista LLC boosted its stake in Walgreens Boots Alliance by 6,403.7% during the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after purchasing an additional 574,218 shares during the period. Finally, Hanson McClain Inc. boosted its stake in Walgreens Boots Alliance by 4.6% during the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock worth $156,000 after purchasing an additional 87 shares during the period. 60.24% of the stock is currently owned by hedge funds and other institutional investors.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Anthony Lederer bought 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance, Inc. (WBA) opened at $66.87 on Friday. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. The firm has a market cap of $67,417.68, a PE ratio of 13.09, a PEG ratio of 1.19 and a beta of 1.20.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.07 EPS. analysts expect that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current year.

Walgreens Boots Alliance declared that its board has authorized a stock buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.39%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.

A number of analysts recently weighed in on the stock. Royal Bank Of Canada assumed coverage on shares of Walgreens Boots Alliance in a research note on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price target for the company. Needham & Company LLC reiterated a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Saturday, September 16th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Jefferies Group LLC reiterated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, UBS Group AG (USA) reiterated a “buy” rating and set a $96.00 price target (down previously from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus target price of $87.63.

TRADEMARK VIOLATION WARNING: This report was reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/barbara-oil-co-has-1175000-position-in-walgreens-boots-alliance-inc-wba/1677285.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.